TY - JOUR
T1 - Renal effects of long-term ciclosporin A treatment in a large animal model
AU - Cibulskyte, Donata
AU - Samsoe Engberg, Anne
AU - Hanefelt Kristensen, Daniel
AU - Ellingsen, Anne Ringer
AU - Ringer Ellingsen, Anne
AU - Pedersen, Michael
AU - Hoerlyck, Arne
AU - Flyvbjerg, Allan
AU - Marcussen, Niels
AU - Hansen, Hans Erik
AU - Madsen, Melvin
AU - Mortensen, Jens
N1 - Copyright 2007 S. Karger AG, Basel.
PY - 2007
Y1 - 2007
N2 - BACKGROUND: Most experimental studies of chronic ciclosporin A (CsA) nephrotoxicity have been performed in rodents; however, the pig possesses several advantages. The aim of this study was to investigate renal functional and structural changes during CsA treatment with 20 mg/kg/day for 6 months in a pig model.METHODS: Gottingen minipigs were randomized to oral CsA treatment or as controls. At 0, 5, 10, 15, 20 and 25 weeks body weight, blood pressure, serum creatinine, and whole blood CsA levels were measured. Magnetic resonance imaging was used to estimate relative glomerular filtration rate (rGFR), renal blood flow (RBF), kidney length and volume. Renal vascular resistance (RVR) was calculated. Kidney tissue biopsies were taken and volume fraction of cortical interstitial tissue estimated by a stereology-based method.RESULTS: CsA induced significant increases in serum creatinine, blood pressure, RVR, and a significant decrease in RBF. Furthermore, renal volume increased significantly. This finding was inversely related to the decrease in RBF and initially followed by an increase in rGFR, which then decreased. No significant histopathological kidney changes were observed.CONCLUSION: CsA treatment with 20 mg/kg/day for 6 months causes increased serum creatinine, blood pressure, RVR, and renal volume along with a decrease in RBF in accordance with data obtained in humans. The initial temporal changes in renal volume and function during CsA administration have similarities to the functional changes seen in early diabetes.
AB - BACKGROUND: Most experimental studies of chronic ciclosporin A (CsA) nephrotoxicity have been performed in rodents; however, the pig possesses several advantages. The aim of this study was to investigate renal functional and structural changes during CsA treatment with 20 mg/kg/day for 6 months in a pig model.METHODS: Gottingen minipigs were randomized to oral CsA treatment or as controls. At 0, 5, 10, 15, 20 and 25 weeks body weight, blood pressure, serum creatinine, and whole blood CsA levels were measured. Magnetic resonance imaging was used to estimate relative glomerular filtration rate (rGFR), renal blood flow (RBF), kidney length and volume. Renal vascular resistance (RVR) was calculated. Kidney tissue biopsies were taken and volume fraction of cortical interstitial tissue estimated by a stereology-based method.RESULTS: CsA induced significant increases in serum creatinine, blood pressure, RVR, and a significant decrease in RBF. Furthermore, renal volume increased significantly. This finding was inversely related to the decrease in RBF and initially followed by an increase in rGFR, which then decreased. No significant histopathological kidney changes were observed.CONCLUSION: CsA treatment with 20 mg/kg/day for 6 months causes increased serum creatinine, blood pressure, RVR, and renal volume along with a decrease in RBF in accordance with data obtained in humans. The initial temporal changes in renal volume and function during CsA administration have similarities to the functional changes seen in early diabetes.
KW - Administration, Oral
KW - Animals
KW - Cyclosporine
KW - Disease Models, Animal
KW - Drug Evaluation, Preclinical
KW - Kidney
KW - Kidney Diseases
KW - Kidney Function Tests
KW - Longitudinal Studies
KW - Swine
KW - Swine, Miniature
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1159/000099003
DO - 10.1159/000099003
M3 - Journal article
C2 - 17259743
SN - 1660-2129
VL - 105
SP - e91-7
JO - Nephron. Experimental nephrology
JF - Nephron. Experimental nephrology
IS - 4
ER -